Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Gilead Sciences, Inc. (GILD) had Weighted-Average Shares Outstanding (Diluted) of 1.25B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$29.44B |
|
$8.51B |
|
$6.23B |
|
$23.21B |
|
$19.42B |
|
$10.02B |
|
$-226.00M |
|
$9.80B |
|
$9.80B |
|
$8.51B |
|
$8.51B |
|
$8.51B |
|
$8.51B |
|
$10.02B |
|
$10.02B |
|
1.24B |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.25B |
$6.84 |
|
$6.78 |
|
| Balance Sheet Financials | |
$19.89B |
|
$5.61B |
|
$39.14B |
|
$59.02B |
|
$11.81B |
|
-- |
|
$24.59B |
|
$36.41B |
|
-- |
|
$-2.67B |
|
$22.62B |
|
1.24B |
|
| Cash Flow Statement Financials | |
$10.02B |
|
$-4.79B |
|
$-7.75B |
|
$9.99B |
|
$7.56B |
|
$-2.43B |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|